Cargando…
Increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care
Sustainable access to essential medicines in low-income and middle-income countries requires innovative cross-sectoral collaboration throughout the lifecycle of a medicine. Partnerships are essential to address the systemic challenges of global health and health inequity. Pharmaceutical companies, f...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453998/ https://www.ncbi.nlm.nih.gov/pubmed/36645765 http://dx.doi.org/10.1136/bmjpo-2022-001467 |
_version_ | 1784785256230944768 |
---|---|
author | DeAngelis, Elena Clarke, Andrew Gibson, Rachel Karrar, Karrar Williams, Pauline |
author_facet | DeAngelis, Elena Clarke, Andrew Gibson, Rachel Karrar, Karrar Williams, Pauline |
author_sort | DeAngelis, Elena |
collection | PubMed |
description | Sustainable access to essential medicines in low-income and middle-income countries requires innovative cross-sectoral collaboration throughout the lifecycle of a medicine. Partnerships are essential to address the systemic challenges of global health and health inequity. Pharmaceutical companies, funders, governments, international non-governmental organisations (I-NGOs) and other key stakeholders can leverage, through effective partnership working, their unique expertise to help drive innovation and share learnings and risks. Here, we reflect on one approach taken in the development and supply of chlorhexidine digluconate 7.1% w/w gel (equivalent to 4% w/w chlorhexidine) for neonatal cord care. We describe and analyse the steps taken by GSK to increase access to chlorhexidine gel, including partnering with the I-NGO Save the Children in Western Kenya. Learning points gained along the journey are shared, together with subsequent steps taken to increase access, with the aim of making recommendations that may be applicable to similar enterprises in the future. |
format | Online Article Text |
id | pubmed-9453998 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-94539982022-09-14 Increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care DeAngelis, Elena Clarke, Andrew Gibson, Rachel Karrar, Karrar Williams, Pauline BMJ Paediatr Open Review Sustainable access to essential medicines in low-income and middle-income countries requires innovative cross-sectoral collaboration throughout the lifecycle of a medicine. Partnerships are essential to address the systemic challenges of global health and health inequity. Pharmaceutical companies, funders, governments, international non-governmental organisations (I-NGOs) and other key stakeholders can leverage, through effective partnership working, their unique expertise to help drive innovation and share learnings and risks. Here, we reflect on one approach taken in the development and supply of chlorhexidine digluconate 7.1% w/w gel (equivalent to 4% w/w chlorhexidine) for neonatal cord care. We describe and analyse the steps taken by GSK to increase access to chlorhexidine gel, including partnering with the I-NGO Save the Children in Western Kenya. Learning points gained along the journey are shared, together with subsequent steps taken to increase access, with the aim of making recommendations that may be applicable to similar enterprises in the future. BMJ Publishing Group 2022-09-06 /pmc/articles/PMC9453998/ /pubmed/36645765 http://dx.doi.org/10.1136/bmjpo-2022-001467 Text en © GSK 2022. Re- use permitted under CC BY- NC. No commercial re- use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Review DeAngelis, Elena Clarke, Andrew Gibson, Rachel Karrar, Karrar Williams, Pauline Increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care |
title | Increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care |
title_full | Increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care |
title_fullStr | Increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care |
title_full_unstemmed | Increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care |
title_short | Increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care |
title_sort | increasing access to essential medicines through partnership: experience in developing and delivering chlorhexidine gel for newborn cord care |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9453998/ https://www.ncbi.nlm.nih.gov/pubmed/36645765 http://dx.doi.org/10.1136/bmjpo-2022-001467 |
work_keys_str_mv | AT deangeliselena increasingaccesstoessentialmedicinesthroughpartnershipexperienceindevelopinganddeliveringchlorhexidinegelfornewborncordcare AT clarkeandrew increasingaccesstoessentialmedicinesthroughpartnershipexperienceindevelopinganddeliveringchlorhexidinegelfornewborncordcare AT gibsonrachel increasingaccesstoessentialmedicinesthroughpartnershipexperienceindevelopinganddeliveringchlorhexidinegelfornewborncordcare AT karrarkarrar increasingaccesstoessentialmedicinesthroughpartnershipexperienceindevelopinganddeliveringchlorhexidinegelfornewborncordcare AT williamspauline increasingaccesstoessentialmedicinesthroughpartnershipexperienceindevelopinganddeliveringchlorhexidinegelfornewborncordcare |